Medinotec Inc.
MDNC
$5.00
$0.000.00%
OTC PK
| 08/31/2025 | 05/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 51.65% | -39.46% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 51.65% | -39.46% | |||
| Cost of Revenue | 2.10% | 6.14% | |||
| Gross Profit | 116.38% | -61.22% | |||
| SG&A Expenses | 136.71% | 46.02% | |||
| Depreciation & Amortization | 0.00% | -56.40% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 45.84% | 18.56% | |||
| Operating Income | 90.49% | -85.84% | |||
| Income Before Tax | 104.26% | -86.34% | |||
| Income Tax Expenses | 27.72% | -66.61% | |||
| Earnings from Continuing Operations | 204.57% | -92.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 204.57% | -92.30% | |||
| EBIT | 90.49% | -85.84% | |||
| EBITDA | 88.11% | -85.46% | |||
| EPS Basic | 209.28% | -91.58% | |||
| Normalized Basic EPS | 107.14% | -84.75% | |||
| EPS Diluted | 209.28% | -91.58% | |||
| Normalized Diluted EPS | 107.14% | -84.75% | |||
| Average Basic Shares Outstanding | -1.55% | -8.49% | |||
| Average Diluted Shares Outstanding | -1.55% | -8.49% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||